✦ LIBER ✦

Endothelin Inhibition as a Biologic Target for Treating Hypertension

✍ Scribed by Hans R Brunner

Book ID: 117604841
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 216 KB
Volume: 11
Category: Article
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(98)00007-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carnitine palmitoyltransferase as a pote

Carnitine palmitoyltransferase as a potential target for treating diabetes: Is inhibition or activation preferable?

✍ Arduino Arduini; Mario Bonomini 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

We read with great interest the article by Teixera-Clerc et al., 1 regarding the hepatoprotective properties displayed by cannabinoid receptor 2 (CB2) agonists in a mouse model of carbon tetrachloride (CCl 4 )-induced liver injury. Acute hepatitis induced by CCl 4 was accelerated in CB2 knockout mic

Phosphodiesterase type 4 as a target for

Phosphodiesterase type 4 as a target for treating asthma

✍ G. Higgs 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Synapsin as a potential new drug target

Synapsin as a potential new drug target for hypertension

✍ Weiguo Zhang; Weiping Han; Thomas C Südhof; Ronald G Victor 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 30 KB

Endothelin-1 as a Target for Therapeutic

Endothelin-1 as a Target for Therapeutic Intervention in Prostate Cancer

✍ E. Scott Kopetz; Joel B. Nelson; Michael A. Carducci 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 316 KB

Alcohol as a Risk Factor and Treatment T

Alcohol as a Risk Factor and Treatment Target for Hypertension

✍ Howard D. Sesso 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 142 KB

Inhibition as a Transplant-Mediated Ther

Inhibition as a Transplant-Mediated Therapy: A New Paradigm for Treating Parkinson's?

✍ Theofanis Karayannis; Gordon Fishell 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 117 KB